Den bästa sidan av 2% pentobarbitalnatrium
pentobarbital will decrease the level or effect of roflumilast ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; strong cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast knipa may reduce the therapeutic effectivenessDailyMed will deliver notification of updates knip